For serious infections, carbapenem preferred until susceptibility known, then step down to aminoglycoside, fluoroquinolone, or TMP-SMX if susceptible.

These organisms often produce inducible beta-lactamase which cause failure of 3rd generation beta-lactam therapy, despite in vitro susceptibility.

Generally susceptible to cefepime and aztreonam.